These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13702520)

  • 1. On the relation between the electronic structure and anti-tumor activity of carcinostatic compounds.
    FUKUI K; NAGATA C; YONEZAWA T; MOROKUMA K; IMAMURA A
    Gan; 1961 Mar; 52():1-14. PubMed ID: 13702520
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor and anti-invasive effects of diverse delta-alkyllactones: dependence on molecular side-chain length, action period and intracellular uptake.
    Tanaka H; Kageyama K; Yoshimura N; Asada R; Kusumoto K; Miwa N
    Life Sci; 2007 Apr; 80(20):1851-5. PubMed ID: 17382354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of carcinostatic activity of omega-hydroxy fatty acids by their esterification through increased uptake into tumor cells.
    Kusumoto K; Kageyama K; Tanaka H; Kogawa H; Miwa N
    Oncol Rep; 2004 Apr; 11(4):857-61. PubMed ID: 15010885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ethyl-esterization, chain-lengths, unsaturation degrees, and hyperthermia on carcinostatic effect of omega-hydroxylated fatty acids.
    Kusumoto K; Kageyama K; Matsuda T; Tomura TT; Munakata H; Tanaka H; Yazama F; Miwa N
    Exp Oncol; 2007 Jun; 29(2):106-10. PubMed ID: 17704741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further investigation on the carcinostatic activity of 4(or 5)-aminoimidazole-5(or 4)-carboxamide derivatives: structure-activity relationship.
    Hano K; Akashi A; Yamamoto I; Narumi S; Iwata H
    Gan; 1968 Jun; 59(3):207-16. PubMed ID: 5701769
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure and carcinostatic activity of certain ethylenephosphoramides. I. Diethylenephenylphosphoramide and derivatives.
    CROSSLEY ML; ALLISON JB; SEEGER DR
    Cancer Res; 1959 Feb; 19(2):142-7. PubMed ID: 13629477
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization studies on the carcinostatic activity of 5-diazouracil.
    SASSENRATH EN; KELLS AM; GREENBERG DM
    Cancer Res; 1959 Apr; 19(3 Pt 1):259-67. PubMed ID: 13638968
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinostatic action of polycarbonyl compounds and their derivatives. I. 3-Ethoxy-2-ketobutyraldehyde and related compounds.
    FRENCH FA; FREEDLANDER BL
    Cancer Res; 1958 Feb; 18(2):172-5. PubMed ID: 13511372
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of metastases by treatment with carcinostatic agents. 3. Low concentration of carcinostatic agents on the cells.
    Kondo T; Ichihashi H; Shizu Y; Momoi Y; Kawashima Y
    Nagoya J Med Sci; 1973 Nov; 36(1):1-10. PubMed ID: 4780531
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental testing of original carcinostatic compounds with potential infracellular activity.
    Nieper HA
    Agressologie; 1966; 7(3):239-45. PubMed ID: 5937300
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paramagnetic diethyleneimides of urethane phosphoric acids as antitumor agents].
    Emanuél' NM; Zhdanov RI; Konovalova NP; Vasil'eva LS; Buina NA
    Vopr Onkol; 1980; 26(5):54-8. PubMed ID: 6247836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro test for sensitivity of tumor to carcinostatic agents.
    Kondo T; Imamura T; Ichihashi H
    Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605
    [No Abstract]   [Full Text] [Related]  

  • 13. [The carcinostatic mechanism of action of ethyleneimino compounds].
    HOLZER H; KROGER H
    Biochem Z; 1958; 330(7):579-90. PubMed ID: 13618247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allergenic and anaphylactoid properties of carcinostatic compounds of platinum].
    Dontsov VI; Tomilets VA; Zakharova IA; Pavlova VI
    Vopr Onkol; 1979; 25(11):47-50. PubMed ID: 516565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell kinetic effect of carcinostatic agents using BrdU and its monoclonal antibody].
    Tsuji Y; Hashimoto K; Takeda J; Kakegawa T
    Nihon Rinsho; 1992 Oct; 50(10):2381-5. PubMed ID: 1333016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinostatic action of polycarbonyl compounds and their derivatives. II. Glyoxal bis (guanylhydrazone) and derivatives.
    FREEDLANDER BL; FRENCH FA
    Cancer Res; 1958 Apr; 18(3):360-3. PubMed ID: 13523604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interference with the activity of some dehydrogenases in intact cells of Ehrlich ascites carcinoma (EAC) as 1 of the criteria in the investigation of carcinostatic antibiotics and other drugs].
    DROBNICA L
    Neoplasma; 1960; 7():385-91. PubMed ID: 13724433
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of cytohistology of human cancer cells in vivo and in vitro--in relation to sensitivity for carcinostatic agents].
    Yoneda T; Imaizumi M; Ichihashi H; Kondo T
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):94-105. PubMed ID: 3998576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental tests of new carcinostatic compounds in HeLa cells].
    Nieper HA
    Arztl Forsch; 1966 Jan; 20(1):18-21. PubMed ID: 6013328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.